Publications

5 résultats Voir en premier : les plus pertinents | les plus récents
    • Maladies, Politique internationale
    • 2010
    • Ouvrage
    • Anglais

    [Lignes directrices pour le dépistage du VIH, l'hépatite virale et d'autres infections chez les usagers de drogues]

    A manual for provider-initiated medical examination, testing and counselling.
    Infectious diseases are among the most serious health consequences of injecting drug use and can lead to significant healthcare costs. Injecting drug users are vulnerable to a range of infectious and communicable diseases through a variety of risk behaviours, and because of underlying
    conditions such as poor hygiene, homelessness and poverty.
    There is a recognised need for guidance on providing IDUs with a medical examination and testing for HIV, viral hepatitis and several other infections on a regular basis. In addition, improving testing uptake in this group would benefit epidemiological surveillance and monitoring as carried out at the national and international level.
    These guidelines are accompanied by a recommended package of prevention and primary care in relation to injecting drug users and infections. Treatment and other specialist care are not discussed in detail but are dealt with by indicating referral to appropriate services.

    • Date de parution:
    • Editeur: European Monitoring Centre for Drugs and drug Addiction (EMCDDA)
    • Santé mentale, Médicaments
    • 2010
    • Ouvrage
    • Anglais

    [Guide d'intervention mhGAP pour les troubles mentaux, neurologiques et liés à l’utilisation de substances dans les établissements de santé non spécialisés: Programme d’action Combler les lacunes en santé mentale (mhGAP)]
    The mhGAP Intervention Guide (mhGAP-IG) for mental, neurological and substance use disorders for non-specialist health settings, is a technical tool developed by WHO to assist in implementation of mhGAP. The Intervention Guide has been developed through a systematic review of evidence followed by an international consultative and participatory process.

    The mhGAP-IG presents integrated management of priority conditions using protocols for clinical decision-making. The priority conditions included are: depression, psychosis, bipolar disorders, epilepsy, developmental and behavioural disorders in children and adolescents, dementia, alcohol use disorders, drug use disorders, self-harm/suicide and other significant emotional or medically unexplained complaints.

    The mhGAP-IG is a model guide and has been developed for use by health-care providers working in non-specialized health-care settings after adaptation for national and local needs.

    • Date de parution:
    • Editeur: Organisation Mondiale de la Santé (OMS) [World Health Organization (WHO)]
    • Accidents et blessures
    • 2010
    • Ouvrage
    • Anglais

    Handbook for measures at the country level.

    The goal of SUPREME was to collect, analyse, summarise and publish best practices in road safety in the Member States of the European Union, as well as in Switzerland and Norway. This document is a collection of best practices at national scale and aims to present the project’s results to national/regional policy and decision makers across Europe, thereby encouraging the adoption of successful road safety strategies and measures. As such, the intention of this project is to contribute to reaching the EU target of a 50 % reduction in road fatalities in 2010 (1).

    The project was commissioned by DG TREN of the European Commission. It started in December 2005 and finished in June 2007.

    A total of 31 national and international road safety organisations were involved. More information about the project and its result can be found at: http://ec.europa.eu/transport/road_safety/pdf/projects/supreme.pdf

    • Date de parution:
    • Editeur: Office des publications de l'Union européenne
    • Maladies
    • 2010
    • Ouvrage
    • Anglais

    [Directives pour l’intensification du dépistage de la tuberculose et l’administration du traitement préventif à l’isoniazide chez les personnes vivant avec le VIH dans un contexte de ressources limitées]
    The guidelines show how people with HIV can be protected from tuberculosis with regular, low-cost preventive medication. The guidelines present a set of recommendations that will help reduce TB disease in people living with HIV, their families and communities through a combination of screening for TB and provision of IPT. Target audience: health-care workers providing care for people living with HIV, policy-makers and health programme managers working in the field of HIV /AIDS and TB.

    • Date de parution:
    • Editeur: Organisation Mondiale de la Santé (OMS) [World Health Organization (WHO)]
    • Maladies, Politique internationale
    • 2010
    • Ouvrage
    • Anglais

    [Lignes directrices européennes pour l'assurance de la qualité dans le dépistage du cancer colorectal]

    The guidelines on colorectal cancer screening form the third and final set of three cancer screening guidelines on breast and cervical cancer published by the Commission to assist Member States in their screening and early detection programmes.

    Today’s publication provides the first ever set of uniform guidelines on all the steps necessary for effective population based colorectal cancer screening in the EU. By implementing them, Member States have the potential to organise their health systems more effectively, including the diagnosis and management of cancers detected in screening. There is good evidence that population-based screening using the EU-recommended test reduces mortality from colorectal cancer by around 15% in people of appropriate age (50 to 74 years) invited to attend screening.

    The guidelines, coordinated for the Commission by the International Agency for Research on Cancer (IARC), were developed with the input of over 90 experts from 32 countries, and set a benchmark for best practice in colorectal cancer screening. Widespread application of the Guidelines should also make it easier for experts in the field to exchange information and experience across the EU. This is essential for innovation and continuous quality improvement of existing cancer screening programmes.

    • Date de parution:
    • Editeur: Publications Office of the European Union
  • Dernière modification le 12-10-2015